LYEL is Lyell Immunopharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $14.37. Market cap: $352M. Capital Quality Rank: 36/100 — Stagnant mediocrity.
Stock snapshot
| Price | $14.37 |
| Market cap | $352M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 36 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -47.4% |
| Revenue CAGR (3y) | -92.5% |
| Shareholder buyback yield | -23.51% |
| Altman Z-score zone | Distress |
About LYEL
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.
Related non-dividend companies
Other non-dividend stocks investors research alongside LYEL. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LYEL's current stock price?
LYEL (Lyell Immunopharma, Inc.) is currently trading at $14.37.
Does LYEL pay a dividend?
LYEL (Lyell Immunopharma, Inc.) does not currently pay a regular dividend.
What is LYEL's Capital Quality Rank?
LYEL has a Capital Quality Rank of 36/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track LYEL in DiviDrip
Add LYEL to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LYEL and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.